Is Xeris Biopharma Holdings Inc. (XERS) the Best Multibagger Penny Stock to Buy According to Billionaires?
From Yahoo Finance: 2025-04-22 18:46:00
In a recent article, we highlighted the 10 Best Multibagger Penny Stocks to Buy According to Billionaires. Penny stocks can offer quick growth opportunities, but they come with high volatility and risk. With the current market correction, interest in penny stocks is rising, attracting notable investors like Donald Trump Jr. and Lara Trump.
Xeris Biopharma Holdings Inc. (XERS) is one of the penny stocks gaining attention. The company has seen a 130.90% gain over the past year, with a share price of $4.11 as of April 21. Xeris focuses on developing innovative therapies in various medical segments and has shown strong revenue growth, particularly in its commercial business.
Xeris Biopharma Holdings Inc. (XERS) has delivered impressive results in 2024, with record revenue of $203 million. The company’s products like Recorlev, Gvoke, and Keveyis have been driving growth. XERS projects a 30% revenue increase in 2025, supported by the potential of XP8121 for hypothyroidism treatment.
Ranked 4th on the list of best multibagger penny stocks, XERS shows promise as an investment. However, the potential for higher returns in a shorter timeframe is seen in AI stocks. Investors looking for more promising opportunities can explore AI stocks, like the cheapest AI stock highlighted in a recent report from Insider Monkey.